A5050499129- Liver Disease Diagnosis and Treatment
- Liver Disease and Transplantation
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Diseases and Immunity
- Abdominal Surgery and Complications
- Pancreatitis Pathology and Treatment
- Systemic Lupus Erythematosus Research
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
2020-2023
BackgroundMetabolic diseases are risk factors for severe Coronavirus disease (COVID-19), which have a close relationship with metabolic dysfunction-associated fatty liver (MAFLD).AimsTo evaluate the presence of MAFLD and fibrosis in patients COVID-19 its association prognosis.MethodsRetrospective cohort study. In hospitalized COVID-19, steatosis was determined by computed tomography scan (CT). Liver assessed using NAFLD score (NFS score), when altered, AST to platelet ratio index (APRI)...
A significant number of patients with liver cirrhosis concomitantly develop some type solid or hematological cancer, including lymphoma. Treatment lymphoma and is challenging for physicians due to the clinical characteristics related cirrhosis, biochemical functional abnormalities, as well portal hypertension lack scientific evidence, limiting use chemotherapy. Currently, experts recommend only offering oncological treatment compensated cirrhosis.To evaluate outcomes in treated...